← FDA DRUG APPROVALS

FDA ANDA · ANDA210409

LORATADINE

Sponsor: HETERO LABS LTD III

APPLICATION
ANDA210409
TYPE
ANDA
ORIGINAL APPROVAL
2021-05-07
LATEST ACTION
2021-05-07
ROUTE
ORAL
DOSAGE FORM
SYRUP
MARKETING STATUS
Over-the-counter

Products

LORATADINEOver-the-counter
LORATADINE 1MG/ML · SYRUP · ORAL

Approval history

2021-05-07UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →